{"product_id":"cerebrolysin-60mg-vial","title":"Cerebrolysin 60mg vial","description":"\u003cp\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e               \u003c\/span\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e                            \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e\u003cstrong data-start=\"377\" data-end=\"392\"\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"text-decoration: underline; color: rgb(255, 42, 0);\"\u003eFOR HUMAN CONSUMPTION\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003ca href=\"https:\/\/www.cerebrolysin.com\/\" data-cke-saved-href=\"https:\/\/www.cerebrolysin.com\" target=\"_blank\"\u003eCerebrolysin\u003c\/a\u003e\u003c\/strong\u003e is\u003cmeta charset=\"UTF-8\"\u003e a \u003cstrong data-start=\"97\" data-end=\"170\"\u003estandardized porcine brain–derived peptide and amino-acid preparation\u003c\/strong\u003e (low–molecular-weight neuropeptides \u0026lt;10 kDa) formulated for \u003cstrong data-start=\"231\" data-end=\"249\"\u003eparenteral use\u003c\/strong\u003e. It exerts \u003cstrong data-start=\"261\" data-end=\"291\"\u003eneurotrophic-like activity\u003c\/strong\u003e—functionally mimicking \u003cstrong data-start=\"315\" data-end=\"327\"\u003eBDNF\/NGF\u003c\/strong\u003esignaling—promoting \u003cstrong data-start=\"348\" data-end=\"415\"\u003eneuronal survival, synaptogenesis, neurogenesis, and plasticity\u003c\/strong\u003e while dampening \u003cstrong data-start=\"432\" data-end=\"491\"\u003eexcitotoxicity, oxidative stress, and neuroinflammation\u003c\/strong\u003e. It is \u003cstrong data-start=\"499\" data-end=\"519\"\u003enot FDA-approved\u003c\/strong\u003e; it is marketed in several countries (ex-US\/UK) for \u003cstrong data-start=\"572\" data-end=\"621\"\u003estroke recovery, traumatic brain injury (TBI)\u003c\/strong\u003e, and \u003cstrong data-start=\"627\" data-end=\"651\"\u003ecognitive impairment\u003c\/strong\u003e based on regional evidence and guidelines.\u003c\/p\u003e\n\u003chr data-start=\"696\" data-end=\"699\"\u003e\n\u003ch3 data-start=\"701\" data-end=\"764\"\u003eAdditional Benefits of Cerebrolysin Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"766\" data-end=\"3340\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"766\" data-end=\"794\"\u003e\n\u003ctr data-start=\"766\" data-end=\"794\"\u003e\n\u003cth data-start=\"766\" data-end=\"776\" data-col-size=\"md\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-start=\"776\" data-end=\"794\" data-col-size=\"xl\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"805\" data-end=\"3340\"\u003e\n\u003ctr data-start=\"805\" data-end=\"1165\"\u003e\n\u003ctd data-start=\"805\" data-end=\"854\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"807\" data-end=\"853\"\u003e1 Post-ischemic stroke functional recovery\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"854\" data-end=\"1165\" data-col-size=\"xl\"\u003eMeta-analyses and RCTs report \u003cstrong data-start=\"886\" data-end=\"926\"\u003eimproved global disability and NIHSS\u003c\/strong\u003e with \u003cstrong data-start=\"932\" data-end=\"983\"\u003eearly IV courses (e.g., 30 mL\/day × 10–20 days)\u003c\/strong\u003e, particularly when paired with structured rehab; heterogeneity and risk of bias remain. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Stroke; Journal of Stroke \u0026amp; Cerebrovascular Diseases; European Stroke Journal\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1166\" data-end=\"1498\"\u003e\n\u003ctd data-start=\"1166\" data-end=\"1215\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1168\" data-end=\"1214\"\u003e2 Traumatic brain injury (moderate–severe)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1215\" data-end=\"1498\" data-col-size=\"xl\"\u003eSignals for \u003cstrong data-start=\"1229\" data-end=\"1270\"\u003ebetter Glasgow Outcome Scale-Extended\u003c\/strong\u003e, \u003cstrong data-start=\"1272\" data-end=\"1304\"\u003efaster cognitive\/motor gains\u003c\/strong\u003e, and \u003cstrong data-start=\"1310\" data-end=\"1336\"\u003elower mortality trends\u003c\/strong\u003e in some cohorts using \u003cstrong data-start=\"1359\" data-end=\"1375\"\u003e10–50 mL\/day\u003c\/strong\u003e cycles; larger contemporary trials are needed. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Neurorehabilitation \u0026amp; Neural Repair; Journal of Neurotrauma\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1499\" data-end=\"1762\"\u003e\n\u003ctd data-start=\"1499\" data-end=\"1543\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1501\" data-end=\"1542\"\u003e3 Vascular\/mixed cognitive impairment\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1543\" data-end=\"1762\" data-col-size=\"xl\"\u003eModest \u003cstrong data-start=\"1552\" data-end=\"1586\"\u003eattention\/executive and memory\u003c\/strong\u003e improvements across small RCTs; effects strengthen when combined with \u003cstrong data-start=\"1657\" data-end=\"1688\"\u003emultidomain cognitive rehab\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;CNS Drugs; International Journal of Geriatric Psychiatry\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1763\" data-end=\"2040\"\u003e\n\u003ctd data-start=\"1763\" data-end=\"1805\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"1765\" data-end=\"1804\"\u003e4 Alzheimer’s disease (symptomatic)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1805\" data-end=\"2040\" data-col-size=\"xl\"\u003eAdd-on to standard care shows \u003cstrong data-start=\"1837\" data-end=\"1890\"\u003eshort-term cognitive and global-function benefits\u003c\/strong\u003e in mild–moderate AD; durability and disease-modification are unproven. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Alzheimer’s Research \u0026amp; Therapy; Journal of Alzheimer’s Disease\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2041\" data-end=\"2280\"\u003e\n\u003ctd data-start=\"2041\" data-end=\"2080\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2043\" data-end=\"2079\"\u003e5 Aphasia \u0026amp; post-stroke language\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2080\" data-end=\"2280\" data-col-size=\"xl\"\u003ePilot trials indicate \u003cstrong data-start=\"2104\" data-end=\"2142\"\u003egreater gains on aphasia batteries\u003c\/strong\u003e when Cerebrolysin is given \u003cstrong data-start=\"2170\" data-end=\"2216\"\u003econcurrently with intensive speech therapy\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Aphasiology; Neuropsychological Rehabilitation\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2281\" data-end=\"2541\"\u003e\n\u003ctd data-start=\"2281\" data-end=\"2313\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2283\" data-end=\"2312\"\u003e6 Motor plasticity \u0026amp; gait\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2313\" data-end=\"2541\" data-col-size=\"xl\"\u003eEnhanced \u003cstrong data-start=\"2324\" data-end=\"2365\"\u003eFugl-Meyer, Barthel Index, gait speed\u003c\/strong\u003e and \u003cstrong data-start=\"2370\" data-end=\"2401\"\u003eDTI\/fMRI plasticity markers\u003c\/strong\u003e when paired with \u003cstrong data-start=\"2419\" data-end=\"2450\"\u003etask-specific physiotherapy\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Neurorehabilitation \u0026amp; Neural Repair; Restorative Neurology \u0026amp; Neuroscience\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2542\" data-end=\"2792\"\u003e\n\u003ctd data-start=\"2542\" data-end=\"2583\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2544\" data-end=\"2582\"\u003e7 Post-ICU\/encephalopathy recovery\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2583\" data-end=\"2792\" data-col-size=\"xl\"\u003eObservational programs suggest \u003cstrong data-start=\"2616\" data-end=\"2655\"\u003efaster cognitive\/functional rebound\u003c\/strong\u003e after toxic-metabolic encephalopathy; controlled evidence is preliminary. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Critical Care Medicine; Frontiers in Neurology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2793\" data-end=\"3056\"\u003e\n\u003ctd data-start=\"2793\" data-end=\"2828\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"2795\" data-end=\"2827\"\u003e8 Neuroprotection biomarkers\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2828\" data-end=\"3056\" data-col-size=\"xl\"\u003eIn models and small human studies: \u003cstrong data-start=\"2865\" data-end=\"2874\"\u003e↑BDNF\u003c\/strong\u003e, \u003cstrong data-start=\"2876\" data-end=\"2884\"\u003e↓NfL\u003c\/strong\u003e, \u003cstrong data-start=\"2886\" data-end=\"2911\"\u003e↓MDA\/oxidative stress\u003c\/strong\u003e, and \u003cstrong data-start=\"2917\" data-end=\"2948\"\u003e↓pro-inflammatory cytokines\u003c\/strong\u003e, paralleling clinical improvements. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Molecular Neurobiology; Frontiers in Aging Neuroscience\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3057\" data-end=\"3340\"\u003e\n\u003ctd data-start=\"3057\" data-end=\"3099\" data-col-size=\"md\"\u003e\u003cstrong data-start=\"3059\" data-end=\"3098\"\u003e9 Combination neurorehab strategies\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"3099\" data-end=\"3340\" data-col-size=\"xl\"\u003eAdditive effects with \u003cstrong data-start=\"3123\" data-end=\"3166\"\u003erobot-assisted therapy, NMES, rTMS\/tDCS\u003c\/strong\u003e, and \u003cstrong data-start=\"3172\" data-end=\"3194\"\u003eearly mobilization\u003c\/strong\u003e, supporting a \u003cstrong data-start=\"3209\" data-end=\"3241\"\u003e“drug-plus-dose-dense-rehab”\u003c\/strong\u003e paradigm. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Clinical Neurophysiology; Archives of Physical Medicine \u0026amp; Rehabilitation\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"3342\" data-end=\"3345\"\u003e\n\u003ch2 data-start=\"3347\" data-end=\"3382\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-start=\"3384\" data-end=\"3410\"\u003e2.1 Pharmacodynamics\u003c\/h3\u003e\n\u003cp data-start=\"3411\" data-end=\"3886\"\u003eCerebrolysin’s peptide fractions activate \u003cstrong data-start=\"3453\" data-end=\"3487\"\u003eTrk receptors (TrkB\/TrkA-like)\u003c\/strong\u003e and downstream \u003cstrong data-start=\"3503\" data-end=\"3515\"\u003ePI3K–Akt\u003c\/strong\u003e and \u003cstrong data-start=\"3520\" data-end=\"3532\"\u003eMAPK–ERK\u003c\/strong\u003e cascades, enhancing \u003cstrong data-start=\"3553\" data-end=\"3561\"\u003eCREB\u003c\/strong\u003e signaling → \u003cstrong data-start=\"3574\" data-end=\"3605\"\u003esynaptic protein expression\u003c\/strong\u003e (synapsin, PSD-95), \u003cstrong data-start=\"3626\" data-end=\"3647\"\u003eneurite outgrowth\u003c\/strong\u003e, and \u003cstrong data-start=\"3653\" data-end=\"3689\"\u003eanti-apoptosis (Bcl-2↑\/caspase↓)\u003c\/strong\u003e. Additional actions include \u003cstrong data-start=\"3718\" data-end=\"3739\"\u003eNMDA\/GABA balance\u003c\/strong\u003e (anti-excitotoxic), \u003cstrong data-start=\"3760\" data-end=\"3785\"\u003emicroglial modulation\u003c\/strong\u003e (NF-κB down-tuning), \u003cstrong data-start=\"3807\" data-end=\"3832\"\u003emitochondrial support\u003c\/strong\u003e, and \u003cstrong data-start=\"3838\" data-end=\"3875\"\u003eamyloid\/tau pathway normalization\u003c\/strong\u003e in models.\u003c\/p\u003e\n\u003ch3 data-start=\"3888\" data-end=\"3915\"\u003e2.2 Down-stream Biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"3917\" data-end=\"4540\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"3917\" data-end=\"3959\"\u003e\n\u003ctr data-start=\"3917\" data-end=\"3959\"\u003e\n\u003cth data-start=\"3917\" data-end=\"3927\" data-col-size=\"sm\"\u003ePathway\u003c\/th\u003e\n\u003cth data-start=\"3927\" data-end=\"3948\" data-col-size=\"md\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-start=\"3948\" data-end=\"3959\" data-col-size=\"sm\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"3974\" data-end=\"4540\"\u003e\n\u003ctr data-start=\"3974\" data-end=\"4069\"\u003e\n\u003ctd data-start=\"3974\" data-end=\"4006\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"3976\" data-end=\"4005\"\u003eBDNF\/TrkB → PI3K–Akt–CREB\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4006\" data-end=\"4047\" data-col-size=\"md\"\u003eNeuronal survival, LTP, synaptogenesis\u003c\/td\u003e\n\u003ctd data-start=\"4047\" data-end=\"4069\" data-col-size=\"sm\"\u003eHippocampus\/cortex\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4070\" data-end=\"4144\"\u003e\n\u003ctd data-start=\"4070\" data-end=\"4085\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4072\" data-end=\"4084\"\u003eMAPK–ERK\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4085\" data-end=\"4122\" data-col-size=\"md\"\u003ePlasticity, learning, neurogenesis\u003c\/td\u003e\n\u003ctd data-start=\"4122\" data-end=\"4144\" data-col-size=\"sm\"\u003eNeurorehab windows\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4145\" data-end=\"4240\"\u003e\n\u003ctd data-start=\"4145\" data-end=\"4174\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4147\" data-end=\"4173\"\u003eNMDA\/GABA re-balancing\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4174\" data-end=\"4215\" data-col-size=\"md\"\u003eAnti-excitotoxicity, network stability\u003c\/td\u003e\n\u003ctd data-start=\"4215\" data-end=\"4240\" data-col-size=\"sm\"\u003eAcute\/subacute injury\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4241\" data-end=\"4330\"\u003e\n\u003ctd data-start=\"4241\" data-end=\"4271\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4243\" data-end=\"4270\"\u003eNF-κB \/ NLRP3 restraint\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4271\" data-end=\"4312\" data-col-size=\"md\"\u003e↓ Microglial cytokines, ↓ inflammation\u003c\/td\u003e\n\u003ctd data-start=\"4312\" data-end=\"4330\" data-col-size=\"sm\"\u003eStroke\/TBI, AD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4331\" data-end=\"4436\"\u003e\n\u003ctd data-start=\"4331\" data-end=\"4362\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4333\" data-end=\"4361\"\u003eOxidative stress control\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4362\" data-end=\"4412\" data-col-size=\"md\"\u003e↓ ROS\/lipid peroxidation; mitochondrial support\u003c\/td\u003e\n\u003ctd data-start=\"4412\" data-end=\"4436\" data-col-size=\"sm\"\u003eIschemia–reperfusion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4437\" data-end=\"4540\"\u003e\n\u003ctd data-start=\"4437\" data-end=\"4461\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4439\" data-end=\"4460\"\u003eAβ\/tau modulation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"4461\" data-end=\"4520\" data-col-size=\"md\"\u003e↓ Amyloid toxicity, ↓ tau hyper-phosphorylation (models)\u003c\/td\u003e\n\u003ctd data-start=\"4520\" data-end=\"4540\" data-col-size=\"sm\"\u003eAD-like settings\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"4542\" data-end=\"4545\"\u003e\n\u003ch2 data-start=\"4547\" data-end=\"4569\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-start=\"4571\" data-end=\"5074\"\u003e\n\u003cli data-start=\"4571\" data-end=\"4655\"\u003e\n\u003cp data-start=\"4573\" data-end=\"4655\"\u003e\u003cstrong data-start=\"4573\" data-end=\"4589\"\u003eComposition:\u003c\/strong\u003e Low-MW neuropeptides and free amino acids; \u003cstrong data-start=\"4633\" data-end=\"4652\"\u003eparenteral only\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4656\" data-end=\"4778\"\u003e\n\u003cp data-start=\"4658\" data-end=\"4778\"\u003e\u003cstrong data-start=\"4658\" data-end=\"4673\"\u003eBBB access:\u003c\/strong\u003e Peptides \u003cstrong data-start=\"4683\" data-end=\"4694\"\u003e\u0026lt;10 kDa\u003c\/strong\u003e and fragments \u003cstrong data-start=\"4709\" data-end=\"4726\"\u003ecross the BBB\u003c\/strong\u003e; pharmacodynamic effects outlast plasma exposure.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4779\" data-end=\"4889\"\u003e\n\u003cp data-start=\"4781\" data-end=\"4889\"\u003e\u003cstrong data-start=\"4781\" data-end=\"4795\"\u003eHalf-life:\u003c\/strong\u003e \u003cstrong data-start=\"4796\" data-end=\"4821\"\u003eShort (minutes–hours)\u003c\/strong\u003e for peptide components; signaling changes persist for days–weeks.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4890\" data-end=\"5074\"\u003e\n\u003cp data-start=\"4892\" data-end=\"5074\"\u003e\u003cstrong data-start=\"4892\" data-end=\"4914\"\u003eDosing in studies:\u003c\/strong\u003e \u003cstrong data-start=\"4915\" data-end=\"4942\"\u003eIV infusion 5–50 mL\/day\u003c\/strong\u003e (often \u003cstrong data-start=\"4950\" data-end=\"4963\"\u003e30 mL\/day\u003c\/strong\u003e) for \u003cstrong data-start=\"4969\" data-end=\"4983\"\u003e10–20 days\u003c\/strong\u003e, repeated \u003cstrong data-start=\"4994\" data-end=\"5014\"\u003eevery 1–3 months\u003c\/strong\u003e in subacute\/chronic phases; IM 5 mL used in some protocols.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"5076\" data-end=\"5079\"\u003e\n\u003ch2 data-start=\"5081\" data-end=\"5126\"\u003e4. Pre-clinical and Translational Evidence\u003c\/h2\u003e\n\u003ch3 data-start=\"5128\" data-end=\"5144\"\u003e4.1 Stroke\u003c\/h3\u003e\n\u003cp data-start=\"5145\" data-end=\"5430\"\u003eRodent and primate stroke models show \u003cstrong data-start=\"5183\" data-end=\"5203\"\u003esmaller infarcts\u003c\/strong\u003e, \u003cstrong data-start=\"5205\" data-end=\"5233\"\u003ebetter neurologic scores\u003c\/strong\u003e, and \u003cstrong data-start=\"5239\" data-end=\"5275\"\u003eenhanced peri-infarct plasticity\u003c\/strong\u003e. Human RCTs\/meta-analyses suggest \u003cstrong data-start=\"5310\" data-end=\"5333\"\u003efunctional benefits\u003c\/strong\u003e with early use + rehab, but \u003cstrong data-start=\"5362\" data-end=\"5385\"\u003etrial heterogeneity\u003c\/strong\u003e(timing, dose, endpoints) tempers certainty.\u003c\/p\u003e\n\u003ch3 data-start=\"5432\" data-end=\"5464\"\u003e4.2 Traumatic Brain Injury\u003c\/h3\u003e\n\u003cp data-start=\"5465\" data-end=\"5637\"\u003eImproved \u003cstrong data-start=\"5474\" data-end=\"5499\"\u003econsciousness metrics\u003c\/strong\u003e, \u003cstrong data-start=\"5501\" data-end=\"5514\"\u003ecognition\u003c\/strong\u003e, and \u003cstrong data-start=\"5520\" data-end=\"5550\"\u003eactivities of daily living\u003c\/strong\u003e reported in several trials\/series; \u003cstrong data-start=\"5586\" data-end=\"5617\"\u003emulti-center, modern-design\u003c\/strong\u003e RCTs are warranted.\u003c\/p\u003e\n\u003ch3 data-start=\"5639\" data-end=\"5668\"\u003e4.3 Cognitive Disorders\u003c\/h3\u003e\n\u003cp data-start=\"5669\" data-end=\"5845\"\u003eIn \u003cstrong data-start=\"5672\" data-end=\"5701\"\u003evascular\/mixed impairment\u003c\/strong\u003e and \u003cstrong data-start=\"5706\" data-end=\"5726\"\u003emild–moderate AD\u003c\/strong\u003e, repeated courses yield \u003cstrong data-start=\"5751\" data-end=\"5797\"\u003emodest cognitive and global-function gains\u003c\/strong\u003e; disease-modifying effects remain \u003cstrong data-start=\"5832\" data-end=\"5844\"\u003eunproven\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cblockquote data-start=\"5847\" data-end=\"6075\"\u003e\n\u003cp data-start=\"5849\" data-end=\"6075\"\u003e\u003cstrong data-start=\"5849\" data-end=\"5875\"\u003eEvidence quality note:\u003c\/strong\u003e The totality of evidence is \u003cstrong data-start=\"5904\" data-end=\"5936\"\u003esupportive but heterogeneous\u003c\/strong\u003e (regional RCTs, varying quality). Benefits appear \u003cstrong data-start=\"5987\" data-end=\"6050\"\u003egreatest when combined with early, intensive rehabilitation\u003c\/strong\u003e and standardized dosing.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-start=\"6077\" data-end=\"6080\"\u003e\n\u003ch2 data-start=\"6082\" data-end=\"6115\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"6117\" data-end=\"6644\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"6117\" data-end=\"6155\"\u003e\n\u003ctr data-start=\"6117\" data-end=\"6155\"\u003e\n\u003cth data-start=\"6117\" data-end=\"6125\" data-col-size=\"sm\"\u003eField\u003c\/th\u003e\n\u003cth data-start=\"6125\" data-end=\"6137\" data-col-size=\"md\"\u003eRationale\u003c\/th\u003e\n\u003cth data-start=\"6137\" data-end=\"6155\" data-col-size=\"sm\"\u003eCurrent status\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"6170\" data-end=\"6644\"\u003e\n\u003ctr data-start=\"6170\" data-end=\"6275\"\u003e\n\u003ctd data-start=\"6170\" data-end=\"6204\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6172\" data-end=\"6203\"\u003eAphasia\/upper-limb recovery\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6204\" data-end=\"6250\" data-col-size=\"md\"\u003eTrophic plasticity + task-specific training\u003c\/td\u003e\n\u003ctd data-start=\"6250\" data-end=\"6275\" data-col-size=\"sm\"\u003ePhase 2–style signals\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6276\" data-end=\"6378\"\u003e\n\u003ctd data-start=\"6276\" data-end=\"6313\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6278\" data-end=\"6312\"\u003ePost-ICU cognitive dysfunction\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6313\" data-end=\"6355\" data-col-size=\"md\"\u003eAnti-inflammatory\/mitochondrial support\u003c\/td\u003e\n\u003ctd data-start=\"6355\" data-end=\"6378\" data-col-size=\"sm\"\u003eObservational\/pilot\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6379\" data-end=\"6459\"\u003e\n\u003ctd data-start=\"6379\" data-end=\"6413\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6381\" data-end=\"6412\"\u003eLong-COVID cognitive issues\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6413\" data-end=\"6444\" data-col-size=\"md\"\u003eNeuroinflammatory modulation\u003c\/td\u003e\n\u003ctd data-start=\"6444\" data-end=\"6459\" data-col-size=\"sm\"\u003eExploratory\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6460\" data-end=\"6549\"\u003e\n\u003ctd data-start=\"6460\" data-end=\"6504\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6462\" data-end=\"6503\"\u003ePerioperative neurocognitive disorder\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6504\" data-end=\"6526\" data-col-size=\"md\"\u003eSynaptic resilience\u003c\/td\u003e\n\u003ctd data-start=\"6526\" data-end=\"6549\" data-col-size=\"sm\"\u003eConcept\/feasibility\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6550\" data-end=\"6644\"\u003e\n\u003ctd data-start=\"6550\" data-end=\"6594\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6552\" data-end=\"6593\"\u003eParkinson’s-related cognitive decline\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"6594\" data-end=\"6627\" data-col-size=\"md\"\u003eSynaptic\/mitochondrial support\u003c\/td\u003e\n\u003ctd data-start=\"6627\" data-end=\"6644\" data-col-size=\"sm\"\u003eEarly studies\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"6646\" data-end=\"6649\"\u003e\n\u003ch2 data-start=\"6651\" data-end=\"6680\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-start=\"6682\" data-end=\"7338\"\u003e\n\u003cli data-start=\"6682\" data-end=\"6851\"\u003e\n\u003cp data-start=\"6684\" data-end=\"6851\"\u003e\u003cstrong data-start=\"6684\" data-end=\"6695\"\u003eCommon:\u003c\/strong\u003e \u003cstrong data-start=\"6696\" data-end=\"6724\"\u003eInjection-site reactions\u003c\/strong\u003e, \u003cstrong data-start=\"6726\" data-end=\"6757\"\u003etransient agitation\/anxiety\u003c\/strong\u003e, \u003cstrong data-start=\"6759\" data-end=\"6772\"\u003edizziness\u003c\/strong\u003e, \u003cstrong data-start=\"6774\" data-end=\"6786\"\u003eheadache\u003c\/strong\u003e, \u003cstrong data-start=\"6788\" data-end=\"6800\"\u003eflushing\u003c\/strong\u003e, \u003cstrong data-start=\"6802\" data-end=\"6814\"\u003esweating\u003c\/strong\u003e, \u003cstrong data-start=\"6816\" data-end=\"6828\"\u003einsomnia\u003c\/strong\u003e; generally \u003cstrong data-start=\"6840\" data-end=\"6848\"\u003emild\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6852\" data-end=\"6967\"\u003e\n\u003cp data-start=\"6854\" data-end=\"6967\"\u003e\u003cstrong data-start=\"6854\" data-end=\"6875\"\u003eLess common\/rare:\u003c\/strong\u003e \u003cstrong data-start=\"6876\" data-end=\"6898\"\u003eAllergic reactions\u003c\/strong\u003e, \u003cstrong data-start=\"6900\" data-end=\"6927\"\u003eblood-pressure lability\u003c\/strong\u003e; avoid in \u003cstrong data-start=\"6938\" data-end=\"6964\"\u003eknown hypersensitivity\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6968\" data-end=\"7064\"\u003e\n\u003cp data-start=\"6970\" data-end=\"7064\"\u003e\u003cstrong data-start=\"6970\" data-end=\"6987\"\u003eSeizure risk:\u003c\/strong\u003e Use caution in \u003cstrong data-start=\"7003\" data-end=\"7028\"\u003euncontrolled epilepsy\u003c\/strong\u003e (excitability symptoms possible).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7065\" data-end=\"7214\"\u003e\n\u003cp data-start=\"7067\" data-end=\"7214\"\u003e\u003cstrong data-start=\"7067\" data-end=\"7089\"\u003eDrug interactions:\u003c\/strong\u003e No major CYP interactions expected; monitor with \u003cstrong data-start=\"7139\" data-end=\"7153\"\u003eCNS-active\u003c\/strong\u003e regimens (sedatives\/stimulants) and \u003cstrong data-start=\"7190\" data-end=\"7211\"\u003eantihypertensives\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7215\" data-end=\"7338\"\u003e\n\u003cp data-start=\"7217\" data-end=\"7338\"\u003e\u003cstrong data-start=\"7217\" data-end=\"7247\"\u003eGeriatrics\/polymedication:\u003c\/strong\u003e Good short-course tolerability in studies; continue routine \u003cstrong data-start=\"7308\" data-end=\"7330\"\u003eBP and neurostatus\u003c\/strong\u003echecks.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"7340\" data-end=\"7369\"\u003e\u003cstrong data-start=\"7340\" data-end=\"7369\"\u003eComparative safety matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"_tableWrapper_1rjym_13 group flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"7371\" data-end=\"7807\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"7371\" data-end=\"7448\"\u003e\n\u003ctr data-start=\"7371\" data-end=\"7448\"\u003e\n\u003cth data-start=\"7371\" data-end=\"7381\" data-col-size=\"sm\"\u003eConcern\u003c\/th\u003e\n\u003cth data-start=\"7381\" data-end=\"7400\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7383\" data-end=\"7399\"\u003eCerebrolysin\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"7400\" data-end=\"7431\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7402\" data-end=\"7430\"\u003eCiticoline (CDP-choline)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"7431\" data-end=\"7448\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7433\" data-end=\"7446\"\u003eEdaravone\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"7467\" data-end=\"7807\"\u003e\n\u003ctr data-start=\"7467\" data-end=\"7510\"\u003e\n\u003ctd data-start=\"7467\" data-end=\"7475\" data-col-size=\"sm\"\u003eRoute\u003c\/td\u003e\n\u003ctd data-start=\"7475\" data-end=\"7494\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7477\" data-end=\"7493\"\u003eIV\/IM cycles\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7494\" data-end=\"7504\" data-col-size=\"sm\"\u003eOral\/IV\u003c\/td\u003e\n\u003ctd data-start=\"7504\" data-end=\"7510\" data-col-size=\"sm\"\u003eIV\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7511\" data-end=\"7629\"\u003e\n\u003ctd data-start=\"7511\" data-end=\"7528\" data-col-size=\"sm\"\u003eEvidence focus\u003c\/td\u003e\n\u003ctd data-start=\"7528\" data-end=\"7563\" data-col-size=\"sm\"\u003eStroke\/TBI, VCI\/AD (symptomatic)\u003c\/td\u003e\n\u003ctd data-start=\"7563\" data-end=\"7592\" data-col-size=\"sm\"\u003eStroke recovery, cognition\u003c\/td\u003e\n\u003ctd data-start=\"7592\" data-end=\"7629\" data-col-size=\"sm\"\u003eALS (JP), stroke (select regions)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7630\" data-end=\"7713\"\u003e\n\u003ctd data-start=\"7630\" data-end=\"7636\" data-col-size=\"sm\"\u003eAEs\u003c\/td\u003e\n\u003ctd data-start=\"7636\" data-end=\"7657\" data-col-size=\"sm\"\u003eMild CNS\/vasomotor\u003c\/td\u003e\n\u003ctd data-start=\"7657\" data-end=\"7679\" data-col-size=\"sm\"\u003eGI, headache (mild)\u003c\/td\u003e\n\u003ctd data-start=\"7679\" data-end=\"7713\" data-col-size=\"sm\"\u003eInfusion reactions, renal risk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"7714\" data-end=\"7807\"\u003e\n\u003ctd data-start=\"7714\" data-end=\"7721\" data-col-size=\"sm\"\u003eRole\u003c\/td\u003e\n\u003ctd data-start=\"7721\" data-end=\"7756\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"7723\" data-end=\"7755\"\u003eNeurotrophic + rehab adjunct\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"7756\" data-end=\"7781\" data-col-size=\"sm\"\u003eMembrane\/choline donor\u003c\/td\u003e\n\u003ctd data-start=\"7781\" data-end=\"7807\" data-col-size=\"sm\"\u003eFree-radical scavenger\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"7809\" data-end=\"7812\"\u003e\n\u003ch2 data-start=\"7814\" data-end=\"7840\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-start=\"7842\" data-end=\"8156\"\u003e\n\u003cli data-start=\"7842\" data-end=\"8000\"\u003e\n\u003cp data-start=\"7844\" data-end=\"8000\"\u003e\u003cstrong data-start=\"7844\" data-end=\"7855\"\u003eStatus:\u003c\/strong\u003e \u003cstrong data-start=\"7856\" data-end=\"7880\"\u003eNot FDA\/EMA-approved\u003c\/strong\u003e; \u003cstrong data-start=\"7882\" data-end=\"7915\"\u003emarketed in several countries\u003c\/strong\u003e as an injectable neuropeptide preparation for \u003cstrong data-start=\"7962\" data-end=\"7997\"\u003estroke\/TBI\/cognitive impairment\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8001\" data-end=\"8156\"\u003e\n\u003cp data-start=\"8003\" data-end=\"8156\"\u003e\u003cstrong data-start=\"8003\" data-end=\"8016\"\u003eGuidance:\u003c\/strong\u003e Best supported as an \u003cstrong data-start=\"8038\" data-end=\"8083\"\u003eadjunct to structured neurorehabilitation\u003c\/strong\u003e with \u003cstrong data-start=\"8089\" data-end=\"8109\"\u003eearly initiation\u003c\/strong\u003e and \u003cstrong data-start=\"8114\" data-end=\"8131\"\u003erepeat cycles\u003c\/strong\u003e where locally permitted.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"8158\" data-end=\"8161\"\u003e\n\u003ch2 data-start=\"8163\" data-end=\"8186\"\u003e8. Future Directions\u003c\/h2\u003e\n\u003cul data-start=\"8188\" data-end=\"8945\"\u003e\n\u003cli data-start=\"8188\" data-end=\"8365\"\u003e\n\u003cp data-start=\"8190\" data-end=\"8365\"\u003e\u003cstrong data-start=\"8190\" data-end=\"8225\"\u003eModern, adequately powered RCTs\u003c\/strong\u003e with \u003cstrong data-start=\"8231\" data-end=\"8285\"\u003estandardized dosing (e.g., 30 mL\/day × 10–20 days)\u003c\/strong\u003e and \u003cstrong data-start=\"8290\" data-end=\"8311\"\u003ecore outcome sets\u003c\/strong\u003e (mRS\/NIHSS, Fugl-Meyer, language batteries, PROMs).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8366\" data-end=\"8485\"\u003e\n\u003cp data-start=\"8368\" data-end=\"8485\"\u003e\u003cstrong data-start=\"8368\" data-end=\"8389\"\u003ePrecision timing:\u003c\/strong\u003e Initiation \u003cstrong data-start=\"8401\" data-end=\"8416\"\u003ewithin days\u003c\/strong\u003e of stroke\/TBI; evaluate \u003cstrong data-start=\"8441\" data-end=\"8458\"\u003edose–response\u003c\/strong\u003e and \u003cstrong data-start=\"8463\" data-end=\"8482\"\u003ecycle frequency\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8486\" data-end=\"8648\"\u003e\n\u003cp data-start=\"8488\" data-end=\"8648\"\u003e\u003cstrong data-start=\"8488\" data-end=\"8513\"\u003eBiomarkers \u0026amp; imaging:\u003c\/strong\u003e \u003cstrong data-start=\"8514\" data-end=\"8532\"\u003eSerum\/CSF BDNF\u003c\/strong\u003e, \u003cstrong data-start=\"8534\" data-end=\"8541\"\u003eNfL\u003c\/strong\u003e, \u003cstrong data-start=\"8543\" data-end=\"8566\"\u003einflammatory panels\u003c\/strong\u003e; \u003cstrong data-start=\"8568\" data-end=\"8580\"\u003eDTI\/fMRI\u003c\/strong\u003e for network plasticity; \u003cstrong data-start=\"8605\" data-end=\"8635\"\u003edigital mobility\/cognition\u003c\/strong\u003e endpoints.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8649\" data-end=\"8802\"\u003e\n\u003cp data-start=\"8651\" data-end=\"8802\"\u003e\u003cstrong data-start=\"8651\" data-end=\"8675\"\u003eCombination therapy:\u003c\/strong\u003e Pair with \u003cstrong data-start=\"8686\" data-end=\"8710\"\u003ehigh-intensity rehab\u003c\/strong\u003e, \u003cstrong data-start=\"8712\" data-end=\"8730\"\u003espeech therapy\u003c\/strong\u003e, \u003cstrong data-start=\"8732\" data-end=\"8744\"\u003erobotics\u003c\/strong\u003e, \u003cstrong data-start=\"8746\" data-end=\"8759\"\u003erTMS\/tDCS\u003c\/strong\u003e; examine \u003cstrong data-start=\"8769\" data-end=\"8780\"\u003esynergy\u003c\/strong\u003eand \u003cstrong data-start=\"8785\" data-end=\"8799\"\u003esequencing\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8803\" data-end=\"8945\"\u003e\n\u003cp data-start=\"8805\" data-end=\"8945\"\u003e\u003cstrong data-start=\"8805\" data-end=\"8831\"\u003eReal-world registries:\u003c\/strong\u003e Safety, adherence, and comparative effectiveness vs \u003cstrong data-start=\"8884\" data-end=\"8920\"\u003eciticoline, memantine, donepezil\u003c\/strong\u003e, and \u003cstrong data-start=\"8926\" data-end=\"8944\"\u003estandard rehab\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"8947\" data-end=\"8950\"\u003e\n\u003ch3 data-start=\"8952\" data-end=\"8975\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-start=\"8977\" data-end=\"9913\"\u003e\n\u003cli data-start=\"8977\" data-end=\"9128\"\u003e\n\u003cp data-start=\"8979\" data-end=\"9128\"\u003e\u003cstrong data-start=\"8979\" data-end=\"9060\"\u003eStroke; European Stroke Journal; Journal of Stroke \u0026amp; Cerebrovascular Diseases\u003c\/strong\u003e — Acute\/subacute stroke trials and meta-analyses of Cerebrolysin.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9129\" data-end=\"9278\"\u003e\n\u003cp data-start=\"9131\" data-end=\"9278\"\u003e\u003cstrong data-start=\"9131\" data-end=\"9218\"\u003eNeurorehabilitation \u0026amp; Neural Repair; Archives of Physical Medicine \u0026amp; Rehabilitation\u003c\/strong\u003e — Functional recovery, motor outcomes, and rehab synergy.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9279\" data-end=\"9373\"\u003e\n\u003cp data-start=\"9281\" data-end=\"9373\"\u003e\u003cstrong data-start=\"9281\" data-end=\"9321\"\u003eJournal of Neurotrauma; Brain Injury\u003c\/strong\u003e — TBI cohorts and functional\/cognitive endpoints.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9374\" data-end=\"9504\"\u003e\n\u003cp data-start=\"9376\" data-end=\"9504\"\u003e\u003cstrong data-start=\"9376\" data-end=\"9436\"\u003eCNS Drugs; International Journal of Geriatric Psychiatry\u003c\/strong\u003e — Vascular\/mixed cognitive impairment and safety in older adults.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9505\" data-end=\"9625\"\u003e\n\u003cp data-start=\"9507\" data-end=\"9625\"\u003e\u003cstrong data-start=\"9507\" data-end=\"9573\"\u003eAlzheimer’s Research \u0026amp; Therapy; Journal of Alzheimer’s Disease\u003c\/strong\u003e — Add-on symptomatic effects in mild–moderate AD.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9626\" data-end=\"9777\"\u003e\n\u003cp data-start=\"9628\" data-end=\"9777\"\u003e\u003cstrong data-start=\"9628\" data-end=\"9687\"\u003eMolecular Neurobiology; Frontiers in Aging Neuroscience\u003c\/strong\u003e — Mechanistic work: neurotrophic signaling, inflammation, oxidative stress, biomarkers.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"9778\" data-end=\"9913\"\u003e\n\u003cp data-start=\"9780\" data-end=\"9913\"\u003e\u003cstrong data-start=\"9780\" data-end=\"9846\"\u003eRestorative Neurology \u0026amp; Neuroscience; Clinical Neurophysiology\u003c\/strong\u003e — Plasticity measures (DTI, fMRI) and combination neuromodulation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Mijn winkel","offers":[{"title":"Default Title","offer_id":52684872417618,"sku":null,"price":75.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/Cerebrolysin.png?v=1770834981","url":"https:\/\/sciencepeptideslab.com\/products\/cerebrolysin-60mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}